ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MPLT vs EOLS // RETURN ON INVESTED CAPITAL (ROIC)

MapLight Therapeutics Inc. (NASDAQ) VS. Evolus Inc. (NASDAQ) • 15-METRIC TALLY: MPLT 2 — EOLS 2
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MPLT
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MPLT VS. EOLS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MPLT EOLS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 66.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -32.40% -35.00% +2.60 MPLT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -9.20% — TIE /fcf-yield <GO>
Operating Margin — -11.00% — TIE /operating-margins <GO>
Net Profit Margin — -17.40% — TIE /net-margins <GO>
Revenue Growth (YoY) — 11.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 EOLS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.5 46.1 -14.65 EOLS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $500.1M $496.7M $3.4M MPLT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MPLT REV EOLS REV MPLT GROSS % EOLS GROSS % MPLT FCF EOLS FCF
FY 2025 $0 $297.2M — 66.3% -$138.6M -$45.7M
FY 2024 $0 $266.3M — 68.5% -$79.6M -$19.5M
FY 2023 — $202.1M — — — -$34.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MPLT // BETA —
EOLS // BETA —